These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors. Qadri SM; Ueno Y; Cunha BA Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and evaluation of alpha-ketoheterocycles as class C beta-lactamase inhibitors. Kumar S; Pearson AL; Pratt RF Bioorg Med Chem; 2001 Aug; 9(8):2035-44. PubMed ID: 11504640 [TBL] [Abstract][Full Text] [Related]
19. 6-(1-Hydroxyalkyl)penam sulfone derivatives as inhibitors of class A and class C beta-lactamases I. Bitha P; Li Z; Francisco GD; Rasmussen BA; Lin YI Bioorg Med Chem Lett; 1999 Apr; 9(7):991-6. PubMed ID: 10230626 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of the -lactamases of Escherichia coli and Klebsiella aerogenes by semi-synthetic penicillins. Cole M; Elson S; Fullbrook PD Biochem J; 1972 Mar; 127(1):295-308. PubMed ID: 4561388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]